Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells.

Article Details

Citation

Copy to clipboard

Li T, Ito K, Horie T

Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells.

Am J Physiol Gastrointest Liver Physiol. 2003 Sep;285(3):G602-10.

PubMed ID

12909565 [ View in PubMed

]

Abstract

The transport characteristics of fluorescein methotrexate (F-MTX) were studied by using the rat intestinal crypt cell line IEC-6. Enhanced accumulation of F-MTX at 4 degrees C suggests the existence of an active efflux system. MK-571, an inhibitor of the multidrug resistance-associated protein/ATP binding cassette C (MRP/ABCC) family, also enhanced the accumulation of F-MTX. Transcellular transport of F-MTX from the apical to the basolateral compartment was 2.5 times higher than the opposite direction. This vectorial transport was also reduced by MK-571, indicating the presence of Mrp-type transporter(s) on the basolateral membrane. Mrp3 mRNA was readily detectable, and the protein was localized on the basolateral membrane. Uptake of FMTX into membrane vesicles from IEC-6 cells and Spodoptera frugiperda-9 cells expressing rat Mrp3 were both ATP dependent and saturable as a function of the F-MTX concentration. Similar Km values (11.0 +/- 1.8 and 4.5 +/- 1.1 microM) and inhibition profiles by MK-571, estradiol-17beta-d-glucuronide, and taurocholate for the ATP-dependent transport of F-MTX into these vesicles were obtained. These findings suggest that the efflux of F-MTX is mediated by Mrp3 on the basolateral membrane of IEC-6 cells.

DrugBank Data that Cites this Article

Drug Transporters

Drug	Transporter	Kind	Organism	Pharmacological Action	Actions
Methotrexate	Canalicular multispecific organic anion transporter 2	Protein	Humans	Unknown	Substrate Inhibitor	Details
Taurocholic acid	Canalicular multispecific organic anion transporter 2	Protein	Humans	Unknown	Substrate Inhibitor	Details